Mypharm eyes 60% share in placenta market
Its Melsmon placenta injection has achieved a bigger market share, backed by better efficacy and safety, since March.
Industry sources generally agree that once Melsmon’s market share hovers the 40 percent level in a country, the p...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
